These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1619985)
1. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985 [TBL] [Abstract][Full Text] [Related]
2. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of thermogenic drugs. Astrup A; Toubro S; Christensen NJ; Quaade F Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887 [TBL] [Abstract][Full Text] [Related]
4. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. Buemann B; Marckmann P; Christensen NJ; Astrup A Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726 [TBL] [Abstract][Full Text] [Related]
5. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Astrup A; Breum L; Toubro S; Hein P; Quaade F Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281 [TBL] [Abstract][Full Text] [Related]
6. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Astrup A; Toubro S Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S41-3. PubMed ID: 8384179 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Toubro S; Astrup AV; Breum L; Quaade F Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186 [TBL] [Abstract][Full Text] [Related]
8. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Toubro S; Astrup A; Breum L; Quaade F Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Molnár D; Török K; Erhardt E; Jeges S Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208 [TBL] [Abstract][Full Text] [Related]
10. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. Liu AG; Smith SR; Fujioka K; Greenway FL Obesity (Silver Spring); 2013 Oct; 21(10):1991-6. PubMed ID: 23686786 [TBL] [Abstract][Full Text] [Related]
11. The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies. Dulloo AG; Miller DS Am J Clin Nutr; 1986 Mar; 43(3):388-94. PubMed ID: 3953478 [TBL] [Abstract][Full Text] [Related]
12. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Westerterp-Plantenga MS; Lejeune MP; Kovacs EM Obes Res; 2005 Jul; 13(7):1195-204. PubMed ID: 16076989 [TBL] [Abstract][Full Text] [Related]
13. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Astrup A; Toubro S; Cannon S; Hein P; Madsen J Metabolism; 1991 Mar; 40(3):323-9. PubMed ID: 2000046 [TBL] [Abstract][Full Text] [Related]
14. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females. Bracale R; Petroni ML; Davinelli S; Bracale U; Scapagnini G; Carruba MO; Nisoli E PLoS One; 2014; 9(6):e98244. PubMed ID: 24905629 [TBL] [Abstract][Full Text] [Related]
15. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931 [TBL] [Abstract][Full Text] [Related]
16. Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats. Malecka-Tendera E Int J Obes Relat Metab Disord; 1993 Jun; 17(6):343-7. PubMed ID: 8392500 [TBL] [Abstract][Full Text] [Related]
17. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Belza A; Frandsen E; Kondrup J Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. Pasquali R; Casimirri F; Melchionda N; Grossi G; Bortoluzzi L; Morselli Labate AM; Stefanini C; Raitano A Clin Sci (Lond); 1992 Jan; 82(1):85-92. PubMed ID: 1310922 [TBL] [Abstract][Full Text] [Related]
19. Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture. Dulloo AG; Miller DS J Nutr; 1987 Feb; 117(2):383-9. PubMed ID: 3559753 [TBL] [Abstract][Full Text] [Related]
20. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women. Horton TJ; Geissler CA Int J Obes Relat Metab Disord; 1996 Feb; 20(2):91-7. PubMed ID: 8646257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]